Stock screener

CGEM

Conviction 100HealthcareScan · Mon, Aug 10, 2026
Bullish engulfing
CGEM$18.31+3.27%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 576.53K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Cullinan Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cullinantherapeutics.com ↗
Price18.31
Change+3.27%
Gap-2.45%
Rel volume2.68×
Avg volume577.58K
Avg $ vol10.09M
SMA 2017.44
SMA 5016.63
SMA 20013.33
Price vs 50+10.08%
Price vs 200+37.34%
MA stackbullish
50/200 cross—
Supertrendup · 15.24
RSI (14)59
MACD hist0.03
MACD crossbull · 0d
Stoch %K / %D95 / 83
ADX (14)13
+DI / −DI18 / 18
RSI divergence—
MACD divergence—
ATR %+5.50%
ADR %5.54%
52w high18.48
52w low5.75
From 52w high-0.92%
Above 52w low+218.43%
New 52w highNo
SqueezeOn · 5d
Bollinger width11.98%
%B0.92
Donchian pos95.07%
Donchian high18.43
Donchian low16.00
AVWAP (52w high)17.79
vs AVWAP high+2.94%
AVWAP (52w low)12.65
vs AVWAP low+44.80%
OBV trendFlat
Chaikin MF (20)-0.02
Today vs 20d2.68×
Avg vol (14d)576.53K
Avg vol (20d)577.58K
Avg $ vol (20d)10.09M
Market cap1.18B
RS 3m (vs SPY)+14.75%
RS 6m (vs SPY)+35.51%
RS line new highNo
Trend template8/8
Technical rank84.8
1 week+12.68%
1 month+0.99%
3 months+25.84%
6 months+49.71%
1 year+160.46%
YTD+80.93%
P/E-5.36
P/B2.88
P/S—
P/FCF-6.70
EPS-3.69
Div yield—
ROE-53.80%
ROA-60.44%
Debt/Eq—
Current8.42
EV/EBITDA-4.56
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-31.36%
Price target33.67
Target upside83.89%
Analyst ratingBuy
Institutional110.64%
Ent. value1.1B
Revenue0
Net income-50.61M
Gross profit—
Free cash flow-175.8M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out61.46M
Employees109
ListedFri, Jan 8, 2021
Free float47.04M
Float %79.6%
Short interest10.29M
Days to cover15.2d
Short volume71.9%
Squeeze score100 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.81 vs −$0.71
Last surprise-14.1% miss
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank84.8 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
News sentiment—

Financials as of Tue, Sep 30, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in CGEM

All disclosures →
No recent disclosed trades by Congress in CGEM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CGEM · 7 buys · 3 sells

InsiderSideShares
Michaelson Jennifer
Chief Scientific Officer · Common Stock · 2026-07-06
Exercise4K
Michaelson Jennifer
Chief Scientific Officer · Common Stock · 2026-07-06
Sell8K
Michaelson Jennifer
Chief Scientific Officer · Stock Option (Right to Buy) · 2026-07-06
Exercise4K
Allen Andrew R
Director · Stock Option (Right to Buy) · 2026-06-16
Grant21.78K
Doyle Mittie
Director · Stock Option (Right to Buy) · 2026-06-16
Grant21.78K
Thistle Mary
Director · Stock Option (Right to Buy) · 2026-06-16
Grant25.32K
Webster Stephen W
Director · Stock Option (Right to Buy) · 2026-06-16
Grant25.32K
Meek David D.
Director · Stock Option (Right to Buy) · 2026-06-16
Grant25.32K
Rosenberg Anthony
Director · Stock Option (Right to Buy) · 2026-06-16
Grant25.32K
Michaelson Jennifer
Chief Scientific Officer · Stock Option (Right to Buy) · 2026-05-05
Exercise4K

SEC filings

EDGAR filings in CGEM · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.